Sanofi
MicroRNA Compounds and Methods for Modulating MIR-21 Activity
Last updated:
Abstract:
Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.
Status:
Application
Type:
Utility
Filling date:
18 Aug 2021
Issue date:
31 Mar 2022